Mohammad AskarPublic working copy · medical review pending

Paediatric uveitis cases · 082

Paediatric uveitis: classification, examination and seven cases

Classify site, course and activity, then use the complete history and systemic findings to distinguish seven different clinical problems. A quiet-looking eye does not exclude inflammation, and a treatment response does not establish its cause.

Public working copy · medical review pending. Source, translation and medical checks remain open. Read the limitations in the text and references. These educational materials do not replace individual medical assessment. Published: 2026-11-18T19:45:52+01:00. Internal project references lead to this notice. They are not publicly accessible primary sources; the source limitations remain stated in the text.

Use SUN grading and definitions consistently. Silent disease requires planned follow-up; select systemic investigations by history and phenotype, and distinguish JIA-specific treatment evidence from other causes.

Terminology and draft status

Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.

01Why paediatric uveitis is different

Paediatric uveitis is often asymptomatic: the eye is not red, the child does not complain, and the disease is found on screening or after vision has already dropped. That is why JIA-associated disease is described as silent. 1

The consequences accumulate: band keratopathy, posterior synechiae, cataract, glaucoma, cystoid macular oedema and amblyopia. A single normal examination does not exclude smouldering inflammation, so interval history and repeated slit-lamp examination matter. 1

Management is multidisciplinary but not leaderless. The ophthalmologist keeps responsibility for ocular follow-up, adherence and the decision to escalate, while rheumatology, nephrology and oncology manage their own domains. 1

02Classification: anatomy, type and course

SUN classifies the predominant site as anterior chamber, vitreous or retina/choroid. The table retains iritis, iridocyclitis, anterior/posterior cyclitis, hyalitis, choroiditis, chorioretinitis, retinochoroiditis, retinitis, neuroretinitis and retinal vasculitis. Panuveitis involves anterior chamber, vitreous and retina/choroid without a predominant site. 1

In the anterior chamber, non-granulomatous disease shows fine white keratic precipitates, while granulomatous disease shows large, greasy, yellowish mutton-fat precipitates that suggest infection or sarcoidosis. The distinction is a clue, not a diagnosis. 1

Acute disease has sudden onset and limited duration. Recurrent episodes are separated by at least 3 months of inactivity without treatment; chronic disease persists or relapses less than 3 months after stopping treatment. SUN remission requires at least 3 months of inactivity off all ocular treatment. 1 2

Classification: anatomy, type and course
TypePredominant siteManifestations
Anterior uveitisAnterior chamber; iris/anterior ciliary involvementIritis, iridocyclitis, anterior cyclitis.
Intermediate uveitisVitreousPars planitis (idiopathic subset), posterior cyclitis, hyalitis.
Posterior uveitisRetina or choroidChoroiditis, chorioretinitis, retinochoroiditis, retinitis, neuroretinitis, retinal vasculitis.
PanuveitisAnterior chamber, vitreous, retina/choroid without predominanceCombined involvement; not just any two sites or every uveal layer.
Classification: anatomy, type and course
PatternClinical clues and limits
NongranulomatousFine white keratic precipitates, possibly circumlimbal redness, marked anterior cells/flare and acute symptoms; no mutton-fat precipitates or iris nodules in the classic pattern. Often noninfectious, but not invariably; steroid response does not establish aetiology.
GranulomatousLarge yellow greasy mutton-fat precipitates on the endothelium, sometimes iris nodules. Consider sarcoidosis and infections including syphilis, TB, herpes and toxoplasmosis; morphology guides rather than proves cause.

03Counting cells in a dark room

Dim the room to improve contrast. The original camera-obscura teaching uses a long narrow-to-medium beam at 45–60 degrees, focused between cornea and lens against the dark pupil, with fine joystick adjustments to see cells. This is a teaching technique; SUN cell grading specifically standardises a 1x1 mm slit field, not a requirement for complete darkness. 1

Use a 1x1 mm field: grade 0 is fewer than 1 cell; 0.5+ is 1–5; 1+ is 6–15; 2+ is 16–25; 3+ is 26–50; 4+ is more than 50. The original attributes fewer than 5 cells as grade 0 and acceptance of 0.5+ to UK practice; that attribution is unverified and conflicts with SUN inactivity, which requires grade 0. 1 2

Flare is protein leakage with blood-aqueous barrier disruption and is graded separately; it is not proof that the disease has become chronic. Grade cells and flare at each visit, with the same beam and the same observer where possible. This light scattering is the Tyndall phenomenon described in the original. 1 2

After focusing on the cornea, move the focal plane posteriorly into the anterior chamber toward the lens, rather than anatomically forward as the original wording suggests. Fine adjustments reveal cells circulating with aqueous convection: warmer fluid near the iris rises, cooler fluid near the cornea descends. This teaching description does not replace the standard 1x1 mm cell count. 1 2

Counting cells in a dark room
GradeFlare descriptionCells in 1x1 mm
0None.Fewer than 1.
0.5+Original dash: no half-grade flare definition in SUN.1–5; not inactive.
1+Faint.6–15.
2+Moderate; iris and lens details clear.16–25.
3+Marked; iris and lens details hazy.26–50.
4+Intense; fibrin or plastic aqueous.More than 50.

04Definitions that change decisions

SUN improvement is at least two steps, or reaching grade 0; worsening is at least two steps, or progression from 3+ to 4+. These thresholds matter when a chart says better without numbers. 1 2

Remission requires at least 3 months of inactive disease off all ocular treatment, rather than more than 3 months as the original says. An eye can be inactive while treated; that is distinct from remission off treatment. Record both activity and treatment status. 1 2

Definitions that change decisions
TermDefinition and original example
InactiveGrade 0 anterior-chamber cells; can be on treatment.
WorseningAt least 2 steps, e.g. 1+ to 3+, or 3+ to 4+; original omits the last alternative.
ImprovementAt least 2 steps, e.g. 3+ to 1+, or to grade 0; original omits the last alternative.
RemissionInactive at least 3 months off all ocular treatment; corrects original more than 3 months.

05Case 1: juvenile idiopathic arthritis

A 3-year-old girl referred for screening had swollen ankles for 6 months without ocular symptoms. The original records ANA positivity, negative rheumatoid factor, fine keratic precipitates, grade 1–2+ cells and early posterior synechiae, attributed to oligoarticular JIA uveitis. Cataract, glaucoma and band keratopathy are complications to prevent, not all documented baseline findings in this case. 1

JIA-associated uveitis is a major cause of noninfectious childhood uveitis, with proportions varying between populations. Its classic pattern is bilateral, chronic, nongranulomatous and silent; pain and redness may appear late after complications have developed. 1

Children with JIA need ophthalmic screening, including boys. ACR risk assessment combines JIA category, ANA positivity, age at onset and disease duration; female sex alone is not its formal high-risk definition. Choose intervals using that assessment and local protocols, rather than assuming symptoms will warn of disease. 1

06Cases 2 and 3: Blau syndrome and TINU

A 5-year-old boy had 6 months of intermittent fever, arthralgia and a papular/nodular rash on trunk and limbs, with chronically red photophobic eyes. The original describes granulomatous anterior uveitis with mutton-fat precipitates and posterior synechiae, raising childhood sarcoidosis/Blau syndrome. Family history and genetic assessment matter; the triad raises suspicion rather than independently proving a molecular diagnosis. 1

Arthritis, rash and recurrent uveitis together suggest childhood sarcoidosis, or Blau syndrome, which is associated with NOD2 variants. NOD2 disease is a spectrum and not every sarcoidosis is NOD2-related; infection must still be excluded in granulomatous uveitis. 1

A 13-year-old boy reported red painful eyes and blurred vision for 3 weeks, fatigue, low-grade fever and weight loss. The original describes bilateral nongranulomatous anterior uveitis with proteinuria and haematuria on dipstick, leading to TINU assessment including creatinine and early nephrology referral. These findings guide the diagnosis but are not a substitute for renal evaluation. 1

TINU is an important consideration in bilateral anterior uveitis in children and adolescents. Urinalysis and renal function help investigate this association, with targeted renal assessment and nephrology input when indicated. The original recommendation to test every child is a proposed baseline approach, not proof that early detection invariably prevents irreversible renal injury. 1

07Cases 4 and 5: post-streptococcal uveitis and pars planitis

A 7-year-old girl developed sudden painful redness and photophobia about ten days after a sore throat. Examination confirmed anterior uveitis and the anti-streptolysin O titre was raised. 1

An acute uveitis one to two weeks after an upper respiratory infection, especially pharyngitis, raises the possibility of immune-mediated post-streptococcal uveitis. A raised ASO titre supports but does not confirm a single aetiology, so other causes are still considered; treatment is topical steroid and, in selected cases, antibiotics. 1

A 7-year-old girl was referred after a white pupillary reflex was seen on a school photograph. Minimal anterior-chamber cells contrasted with vitreous snowballs, peripheral snowbanking and OCT-confirmed cystoid macular oedema. Snowbanks are inflammatory deposits over the pars plana/peripheral retina, not simply a synonym for vascular change; examine the periphery, with indentation when appropriate. 1

Intermediate uveitis is a differential for floaters and blurred vision; its main complications are cystoid macular oedema and vitreous haemorrhage, and fluorescein angiography can help assess vasculitis. Pars planitis is idiopathic intermediate uveitis with snowballs or snowbanks, not a synonym for every intermediate case. 1

08Cases 6 and 7: toxocara and masquerade

An 11-year-old boy with floaters and photophobia lived with a dog and cat, with no regular deworming documented. The original records granulomatous panuveitis, vitritis, a chorioretinal granuloma near the optic nerve and marked blood eosinophilia. Exposure supports the differential but contact alone does not establish ocular toxocariasis. 1

Unilateral granulomatous disease with posterior involvement raises ocular toxocariasis. Serum antibodies and eosinophilia support a compatible presentation but do not independently confirm every ocular case; eosinophilia can be absent. Albendazole and steroid cover are specialist decisions to balance organism-directed treatment and inflammatory worsening, not a universal regimen. 1

A 5-year-old girl in follow-up after treated leukaemia developed an acutely painful red eye with hypopyon, resistant to intensive topical steroids. The original reports anterior-chamber cytology confirming an intraocular leukaemic relapse. Communicate urgently with oncology and plan sampling with specialists; this case does not prove that every similar puncture is life-saving. 1

Masquerade disorders imitate primary uveitis and may themselves cause secondary inflammation; intraocular leukaemic infiltration is an important paediatric example, but the original commonest-cause claim is not verified across populations. Hypopyon is layered anterior-chamber material, not necessarily infectious pus. Leukocoria needs urgent assessment to exclude retinoblastoma. Steroid-resistant hypopyon with a cancer history needs urgent oncology and uveitis input; anterior chamber sampling is an individual specialist decision. 1

09Management: treat, taper, monitor, coordinate

Take a focused history of joints, skin, fever and infections, and assess systemic involvement. The original proposes blood count, urinalysis and blood pressure as a core screen; tailor investigations to age, presentation and suspected association rather than treating a fixed panel as diagnostic. 1

Selected noninfectious anterior uveitis may need intensive topical steroid, with hourly treatment as an original teaching example and a taper over weeks to months guided by activity. This is not a regimen for every posterior or infectious cause. Assess infection and monitor intraocular pressure, cataract and steroid response. 1

For JIA-associated noninfectious uveitis, ACR recommendations support methotrexate or selected monoclonal anti-TNF therapy according to steroid dependence, activity and sight-threatening complications, mostly with very low-certainty evidence. These recommendations do not cover every cause of childhood uveitis. High-risk JIA screening is approximately every 3 months; controlled established JIA uveitis is monitored at least every 3 months, sooner around treatment changes. Ophthalmology coordinates ocular care with the other teams. 1 3

The original suggests initially weekly follow-up and quotes a 30% population steroid-pressure response. The source, drug, exposure and threshold for that percentage are unverified; it is not an individual paediatric risk estimate. Adjust review frequency to activity, treatment changes and complications, and monitor pressure without relying on a fixed weekly rule. 1 3

What are the main learning points?

Use SUN grading and definitions consistently. Silent disease requires planned follow-up; select systemic investigations by history and phenotype, and distinguish JIA-specific treatment evidence from other causes.

When is assessment urgent?

Leukocoria needs urgent assessment to exclude retinoblastoma. Steroid-resistant hypopyon, especially with a cancer history, needs urgent specialist assessment for masquerade and other causes. Pain, falling vision or new synechiae should not wait for a routine appointment.

References and access status

  1. 1
    Immutable original paediatric uveitis case export; biography/attribution unchecked

    Complete own export and all table cells read 10 November 2026. Original attribution, professional biography, success claims, recording and case source records not independently verified.

  2. 2
    Standardization of Uveitis Nomenclature (SUN) working group definitions and grading

    Parent-selected access 10 November 2026: the parent reviewer read the full SUN tables 1-5 and definitions (absolute cell counts in a 1x1 mm field, improvement/worsening, remission at least 3 months off treatment). This drafting pass relied on that reported extraction and did not re-open the article. Reused from parent review 080 with the recorded scope; not a new full-source reading.

  3. 3
    ACR/AF 2019 guideline for JIA-associated uveitis (selected table 3 and recommendations)

    10 November 2026: parent read selected table 3 and recommendations for JIA-associated uveitis, including screening and monitoring every 3 months, earlier review during treatment changes, methotrexate and selected monoclonal anti-TNF. Mostly very low-certainty evidence; dosing tables and complete guideline not appraised. Reused from parent review 080 with the recorded scope; not a new full-source reading.

Original lecture link